foxo4 dri peptide senolytic 2024 The disordered p53 transactivation domain is the target of and the compound FOXO4-DRI FOXO4-DRI induces keloid senescent fibroblast
Description
Together, these studies highlight Epithalon as a peptide of significant interest in aging and cellular biology research
Advanced peptide blend featuring stable BPC-157 argininate and Thymosin Beta-4 (TB-4) fragment, studied in laboratory models for tissue repair, angiogenesis, cytoskeletal remodeling, and regenerative pathway research
Independently lab-tested for purity, with high-quality ingredients for 100% traceability
Individuals Looking To Expand Their Treatment Portfolio
Anti-inflammatory pathways
The product stimulates appetite, which improves feed intake and ultimately enhances growth, weight gain and production
